It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, glucagon-like peptide-1 receptor agonists (GLP-1s) are medicines that help people ...

Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on each patient’s clinical condition when determining initial treatment, ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning for anyone taking Ozempic, Wegovy, Rybelsus, or Mounjaro. The health body made the appeal on social media for anyone ...

Healthcare stocks can provide growth and consistent returns through a variety of market cycles. Eli Lilly has a storied ...

It made the call for anyone suffering from a 'severe reaction' to GLP-1 medicine. According to the Government website, glucagon-like peptide-1 receptor agonists (GLP-1s) are medicines that help people ...

Getty Ozempic-style weight loss jabs, including Mounjaro, are now used by 1.5million Brits, and new data revealed that they are even affecting supermarket sales. They work by affecting the hormones ...

Tirzepatide, a medication sold under the names Mounjaro for diabetes and Zepbound for weight loss, has shown impressive results in helping people avoid developing diabetes. A new study found that it ...

Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO stock is a buy.

Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating ...

The British TV star Jeremy Clarkson said he had an unexpected blunder while at airport security as a result of taking Mounjaro.

Viking Therapeutics delivered a disappointing earnings report on October 22, revealing a quarterly loss of $0.81 per share that fell substantially short of ...

El ensayo clínico, que busca reclutar a 1000 pacientes con COVID persistente en todo el país, explorará cómo la autoadministración de tirzepatida, el agonista del GLP-1 de Eli Lilly comercializado ...